Literature DB >> 32934125

COVID-19 in Patients With Connective Tissue Disease-related Interstitial Lung Disease.

Linh Truong1, Lila Pourzand2, Elizabeth R Volkmann3.   

Abstract

Entities:  

Year:  2020        PMID： 32934125      PMCID： PMC7956905          DOI： 10.3899/jrheum.201064

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  5 in total

1.  COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD.

Authors:  Carina Mihai; Rucsandra Dobrota; Maria Schröder; Alexandru Garaiman; Suzana Jordan; Mike Oliver Becker; Britta Maurer; Oliver Distler
Journal:  Ann Rheum Dis       Date:  2020-04-02       Impact factor: 19.103

2.  Mycophenolic acid and methotrexate inhibit lymphocyte cytokine production via different mechanisms.

Authors:  Sacha de Lathouder; Andreas H Gerards; Els R de Groot; Marijke Valkhof; Lucien A Aarden
Journal:  Eur Cytokine Netw       Date:  2002 Jul-Sep       Impact factor: 2.737

3.  Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.

Authors:  Chaomin Wu; Xiaoyan Chen; Yanping Cai; Jia'an Xia; Xing Zhou; Sha Xu; Hanping Huang; Li Zhang; Xia Zhou; Chunling Du; Yuye Zhang; Juan Song; Sijiao Wang; Yencheng Chao; Zeyong Yang; Jie Xu; Xin Zhou; Dechang Chen; Weining Xiong; Lei Xu; Feng Zhou; Jinjun Jiang; Chunxue Bai; Junhua Zheng; Yuanlin Song
Journal:  JAMA Intern Med       Date:  2020-07-01       Impact factor: 21.873

4.  Clinical course and mortality risk of severe COVID-19.

Authors:  Paul Weiss; David R Murdoch
Journal:  Lancet       Date:  2020-03-17       Impact factor: 79.321

5.  Clinical characteristics of COVID-19 in patients with preexisting ILD: A retrospective study in a single center in Wuhan, China.

Authors:  Hong Huang; Ming Zhang; Can Chen; Huilan Zhang; Yanqiu Wei; Jianbo Tian; Jin Shang; Yan Deng; Aihua Du; Huaping Dai
Journal:  J Med Virol       Date:  2020-08-02       Impact factor: 20.693
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.